WAT Waters Corporation
Health Care · S&P 500
Next earnings: not announced yet
What 26 analyst firms say about Waters Corporation: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
21 rated views · 26 analyst/firm records · 26 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8049
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8077
Recent analyst activity · last 90 days
Our tracked history has 24 reports on WAT from 18 analyst firms in the last 90 days (26 firms in the past year).
Comparing each firm's latest target with its previous one: 14 raised their price target and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 2 upgrades and 0 downgrades.
Latest observed target change: Barclays raised its target from $500.00 (set 7 Oct 2026) to $530.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Catherine W Schulte | Buy | 13 Jul 2026 | Conflicting reports · excluded |
| Bank of America Securities | Derik De Bruin | Hold | 2 Jun 2026 | 400.00 USD |
| Barclays | Luke Sergott | Buy | 7 Oct 2026 | 500.00 USD |
| Bernstein | Eve Burstein | Buy | 26 Sep 2026 | Conflicting reports · excluded |
| Citigroup | Joanne Wuensch | Buy | 10 Aug 2026 | 470.00 USD |
| Deutsche Bank | Justin Bowers | Hold | 5 Aug 2026 | 400.00 USD |
| Evercore ISI | Vijay Kumar | — | 7 Oct 2026 | 480.00 USD |
| Goldman Sachs | Evie Koslosky | Buy | 21 Sep 2026 | 515.00 USD |
| Guggenheim | Subbu Nambi | Buy | 1 Oct 2026 | 490.00 USD |
| HSBC | Sidharth Sahoo | Buy | 1 Sep 2026 | 455.00 USD |
| Jefferies | Tycho W Peterson | Buy | 4 Nov 2026 | 525.00 USD |
| JPMorgan | Casey Woodring | — | 14 Oct 2026 | 435.00 USD |
| KeyBanc Capital Markets | Paul Knight | Buy | 4 Nov 2026 | 500.00 USD |
| Leerink Partners | Puneet Souda | Buy | 5 Aug 2026 | 450.00 USD |
| Morgan Stanley | Kallum Titchmarsh | — | 5 Aug 2026 | 430.00 USD |
| Piper Sandler | David Westenberg | Buy | 27 Aug 2026 | 480.00 USD |
| RBC Capital Markets | Dan Leonard | Buy | 4 Nov 2026 | 525.00 USD |
| Redburn | Natalya Davies | Buy | 6 Aug 2026 | Conflicting reports · excluded |
| Stifel | Daniel Arias | — | 5 Aug 2026 | 420.00 USD |
| TD Cowen | Daniel Brennan | Buy | 4 Nov 2026 | 530.00 USD |
| UBS | Doug Schenkel | Buy | 9 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Evan Stampler | Hold | 5 Aug 2026 | 400.00 USD |
| William Blair | Matt Larew | Buy | 5 Aug 2026 | — |
| Wolfe Research | Mike Polark | Buy | 4 Nov 2026 | 520.00 USD |
| Data feed RESEARCH | Research Team | Hold | 9 Feb 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:34 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.